Presentation is loading. Please wait.

Presentation is loading. Please wait.

SPEAKER’S PROFILE Drs. Jahja Santoso, Pharmacist

Similar presentations


Presentation on theme: "SPEAKER’S PROFILE Drs. Jahja Santoso, Pharmacist"— Presentation transcript:

1 SPEAKER’S PROFILE Drs. Jahja Santoso, Pharmacist
Educational background : Bandung Institute of Technology, Pharmacy college. Current Functions : Owner and President Director of PT Sanbe Farma, the largest pharmaceutical manufacturing company in Indonesia among more than 200 pharmaceutical companies. (website : Owner and President Director of PT Caprifarmindo Laboratories (website : Owner of Santosa Bandung International Hospital (website : Owner and President Director of PT Bina San Prima, General Trading & Distributor (website : Owner of the Holiday Inn International Hotel in Bandung / Ibis Hotel in Semarang Member Board of Trustee, Padjadjaran University Honorary Title Prince of Central Java Kingdom Founder of Santoso Charity Foundation with 75 orphanage houses and 2,000 students with scholarship. Honorary Consul of The Republic of Latvia, for West Java & Bali (Indonesia) Owner of San Diamond Jewelry

2 Invest in Presented by : Drs. Jahja Santoso, Pharmacist
Honorary Consul of The Republic of Latvia For West Java & Bali June 07, 2011

3 INDONESIA Population : 240,000,000 people
Biggest archipelago country in the world - Island : > 17,000 - Lands : ± 2 million km2 - Sea : ± 5,8 million km2 - Coastal line : ± 81,000 km Population : 240,000,000 people Hundreds of ethnics More than 750 languages & dialects One of biggest democratic country 6,435 Km

4 Snapshot of Indonesia’s Macro Condition
GDP (Qtr II-2010) 6.0% Foreign exchange (FX) Reserves (Qtr II-2010) USD 76.3 Billion Interest Rate (as per July ‘10) 6.50 % Foreign Debt Ratio (Qtr II-2010) 28.3 % Inflation (until September 2010) 5.28% Note : Nominal per-capita GDP is expected to quadruple by 2020 as per Standard Chartered Source: Bank Indonesia, Investment Coordinating Board / BKPM 4

5 INDONESIA’S UNIQUE STRENGTHS AND OPPORTUNITIES
KEY STRENGTHS Dynamic and youthful population Of the 240 million people in Indonesia, over 50% of the population is under 29 years old Rapidly urbanizing population provides for labor force in centers of investment Dynamic labor market participation with a growth of 2.3 million people per year

6 INDONESIA’S UNIQUE STRENGTHS AND OPPORTUNITIES
KEY STRENGTHS 2. Abundance of natural resources Crude Oil Natural Gas Thermal Coal Geothermal Key Metrics Over 3.5 billion barrels of proven reserves About 112 ton cubic feet of reserves World’s second largest exporter Home to 40% of world’s resources

7 INDONESIA’S UNIQUE STRENGTHS AND OPPORTUNITIES
KEY STRENGTHS 2. Abundance of natural resources Palm oil Cocoa Tin Key Metrics World’s largest exporter, producing about 19 million tons per year At 779 thousand tons per year, world’s second largest producer At 65 thousand tons per year, world’s second largest producer

8 INDONESIA’S UNIQUE STRENGTHS AND OPPORTUNITIES
KEY STRENGTHS 3. Burgeoning Domestic Market The services sector has grown over 16 percentage points from 1998 to 2009. Private consumption accounts for 70% of GDP and has increased by 5.3% in 2008 Consumer confidence index rose by nearly 10% in November 2009 (year-on-year) Over 50% of the population live in urban areas and adopt a modern lifestyle

9 INDONESIA’S UNIQUE STRENGTHS AND OPPORTUNITIES
KEY STRENGTHS 4. Strategic Location and Increasing Global Presence Indonesia lies strategically in the intersection of the Pacific Ocean, along the Malacca Straits and the Indian ocean Over half of all international shipping travel through Indonesian waters The only country in South-east Asia that is a member of G-20 An active and strong voice of developing countries in global discussions on issues around climate change, global economy architecture, etc

10 INDONESIA’S UNIQUE STRENGTHS AND OPPORTUNITIES
KEY STRENGTHS 5. Increasingly skilled labor force Government is committed to making education a priority: Education spending accounts for 16% of total government expenditures University graduates are trained in technical fields such as finance and economics (28%) or engineering and sciences (27.5%) Labor cost is relatively low (USD 0.6 per hour), even as compared to investment magnets China (USD 2.11 per hour) and India (USD 1.03 per hour)

11 INDONESIA’S UNIQUE STRENGTHS AND OPPORTUNITIES
KEY STRENGTHS 6. On-going reform in investment climate Investment Law (2007) - Equal Treatment for foreign & domestic investors - No Minimum Capital Requirement - Divestment not required - Free to Repatriate Investment & Profit - Legal Guarantee - Dispute Settlement - Investment Services Establishment of a one-door integrated service and a national single window for investment, enhancing investment coordination and facilitation. Listed as one of ten countries improving investor protections as per Doing Business Report 2010 by IFC (International Finance Corporation)

12 Stimulus Tax and Duties covered by government
Income Tax Reduction for Individual & Geothermal Development Speeding Up Infrastructure Development Discount Price for Power & Energy Intensify discussion on facilities for foreign investments including integrated services and reviewing of fiscal facilities

13 2010 Foreign Direct Investment (FDI) Confidence Index

14 Conclusion Indonesia with its big population, abundant natural resources, on-going reform in investment climate is a promising country for investment. Government has commitment to support investment in Indonesia with its Investment Law 2007. Indonesia is ranked as the 20th FDI (Foreign Direct Investment) destination country in 2010.

15 For further information, please contact :
* INDONESIA INVESTMENT COORDINATING BOARD Chairman : Gita I. Wirjawan Deputy Chairman of Investment Promotion : Ir. Darmawan Dj., MA Website : Office Address : Jl. Jend. Gatot Subroto No. 44, Jakarta 12190 P.O. Box 3186, Indonesia Phone : Fax :

16 INDONESIAN PHARMACEUTICAL OVERVIEW
Presented by : Drs. Jahja Santoso, Pharmacist Honorary Consul of The Republic of Latvia For West Java & Bali June 07, 2011

17 INDONESIAN CONDITION Drug consumption Per capita/year Year US $ 2004
8.2 2005 8.8 2006 9.0 2007 10.0 2008 12.0 Hospitals 1,200 Total Doctors 40,000 Specialist 10,000 General Practitioner 24,000 Dentist ,000 Ratio Doctor to Patient: Way below WHO standard Primary Health Care 7,000 Pharmacies 7,000

18 HEALTH BUDGET IN INDONESIA
FROM YEAR TO YEAR IDR 5.8 trillion IDR 13.5 trillion IDR 15.1 trillion IDR 16 trillion IDR 19.3 trillion IDR 26 trillion Source : from various sources Note : USD 1 = Rp 9,000

19 Health Expenditure Comparison in ASEAN countries
Country Health Expenditure (as % of GDP) Vietnam 6.6 Cambodia 6.0 Malaysia 4.3 Laos 3.6 Thailand 3.5 Singapore 3.4 Philippines 3.3 Myanmar 2.3 Indonesia 2.2

20 INDONESIAN PHARMACEUTICAL MARKET
Pharma Market size in 2010 : around USD 4 Billion Market growth : % per year There are presently 200 local and 35 foreign pharmaceutical companies Patent Law: effective as of 1 January 2000

21 INDONESIAN PHARMACEUTICAL MARKET
Pharma Market Characteristic : Capital Intensive High tech, Highly fragmented, Highly regulated Multiproduct line High imported content Small percentage of people covered by insurance

22 PHARMA MARKET TREND IN INDONESIA Value in billion rupiah
Value in billion rupiah Year TOTAL MARKET ETHICAL DRUG GENERIC DRUG 2001 12,850 7,891 1,547 2002 15,483 9,618 1,694 2003 17,458 10,829 1,819 2004 20,872 12,706 2,136 2005 23,629 14,675 2,529 2006 23,173 13,834 2,390 2007*)  25,027 11,899 2,222 Source : Bisnis Indonesia 12 Feb 2008 Note : USD 1 = Rp 9,000

23 BIG FIVE PHARMACEUTICAL COMPANIES IN INDONESIA
Company Market Share (%) KALBE FARMA 6.99 SANBE FARMA 5.23 SOHO 4.03 DEXA MEDICA 3.76 TEMPO SCAN PACIFIC 3.55 Source : Suara Pembaruan daily newspaper, September 25, 2010

24 Share of OTC & Prescription - Pharma Market
Total Registered Product: 15,911 Items Source : IMS Health 24

25 PRESCRIPTION PHARMACEUTICAL MARKET SHARE
Source : IMS Health, Fiscal Year 2009 (Ethical)

26 PRESCRIPTION PHARMACEUTICAL MARKET SHARE
Source : IMS Health, Fiscal Year 2009 (Ethical)

27 EXPORTED PHARMACEUTICAL PRODUCT FROM INDONESIA
AND JANUARY-JULY 2006 VALUE IN THOUSAND US$ HS PRODUCT 2001 2002 2003 2004 2005 % Share 2005 % Trend JAN-JULY 2005 JAN-JULY 2006 % change 2006/2005 3001 Glands etc dry & ext, heparin, hum etc subst nesoi 339 2,898 1,107 527 42 0.04 -44.52 12 13 3.63 3002 Human blood, animal blood, antisera, vaccines etc 3,848 7,380 6,878 10,999 7,044 7.26 17.45 4,886 5,737 17.41 3003 Medicaments nesoi of mixtures, not dosage etc form 15,706 18,923 23,735 20,230 15,158 15.62 -0.04 9,768 5,894 -39.66 3004 Medicaments nesoi, mixed or not, in dosage etc fm 44,382 46,289 60,074 76,606 64,933 66.91 13.48 41,198 43,509 5.61 3005 Bandages etc coated etc or in retail medic etc fm 6,622 2,487 2,549 1,323 1,644 1.69 -28.95 980 1,253 27.85 3006 Pharmaceutical goods (specified sterile prod etc.) 5,003 9,228 9,963 8,452 8,225 8.48 9.49 4,318 6,730 55.84 TOTAL 75,898 87,205 104,306 118,137 97,046 100.00 8.28 61,163 63,135 3.22 Source : Central Bureau of Statistics

28 IMPORTED PHARMACEUTICAL PRODUCTS TO INDONESIA FROM COUNTRY OF ORIGIN in AND JANUARY-JULY 2006 VALUE IN THOUSAND US$ NO. COUNTRY 2001 2002 2003 2004 2005 % SHARE 2005 % TREND JAN-JULY 2005 JAN-JULY 2006 % CHANGE 2006/2005 1 Germany 17,426 15,702 27,242 41,358 26,494 13.94 19.80 15,830 23,146 46.21 2 France 7,114 11,278 12,324 15,499 19,895 10.47 26.80 9,579 13,758 43.63 3 USA 13,339 13,581 12,494 15,218 17,530 9.22 6.83 9,669 15,296 58.20 4 Switzerland 4,556 7,315 11,196 14,357 14,782 7.78 35.37 9,643 9,701 0.61 5 UK 5,124 6,295 9,043 9,469 13,035 6.86 25.55 7,603 8,214 8.04 6 Italy 3,538 4,352 5,123 8,168 11,255 5.92 34.23 7,184 7,519 4.66 7 Japan 2,404 3,845 4,205 6,167 10,232 5.38 40.06 4,381 5,833 33.16 8 South Korea 784 3,309 6,293 6,967 9,048 4.76 75.69 5,707 7,541 32.13 9 Belgium 2,721 4,656 3,458 5,125 8,469 4.45 26.71 3,944 5,875 48.96 10 Netherlands 4,074 6,002 7,668 8,698 8,412 4.43 19.98 4,545 7,662 68.58 Others 20,820 22,526 28,177 40,548 50,948 26.84 29,319 44,362 33.91 TOTAL 81,898 98,862 127,223 171,574 190,100 100.00 25.05 107,404 148,908 38.64 Source : Central Bureau of Statistics

29 Pharmaceutical Business Condition
The Indonesia Pharmaceutical market is still potential enough considering the population number, GDP and drug consumption. Industry needs to invest in order to comply with cGMP regulation Minister of Health Decree No. 1010/Menkes/PER/XI/2008: Registration of imported drug shall be performed by domestic pharmaceutical industry with written authorization from foreign pharmaceutical industry. Technology transfer shall be done within 5 years the latest in order that the product be produced locally. Regulation about National Social Security System / SJSN and Health Insurance for poor population.

30 OPPORTUNITY FOR PHARMACEUTICAL INDUSTRY
Opportunity to grow is still available for pharmaceutical industry in Indonesia : Indonesia as one country with the lowest medicine consumption per capita in ASEAN Indonesian vision to be high income country in 2030 (US$18,000 per capita) Indonesian people is projected to be 285 million in 2030 Source : Yayasan Indonesia Forum 2007; Bisnis Farmasi 2007, WordPress.com 30

31 GP Farmasi (Indonesian Pharmaceutical Association)
For Further information, please contact : GP Farmasi (Indonesian Pharmaceutical Association) The only pharmaceutical association in Indonesia: covering Manufacturer, Distributor, Pharmacy & Drug Stores based on Ministry of Health Decree no 222/1969 Members: Foreign National (4 State Owned) Wholesaler ,463 Pharmacy ,671 Drug store ,513 (Licenced)

32 Chairman of GP Farmasi :
Mr. Anthony CH. Sunarjo, MBA. ( address : Executive Secretary : Buddy Nataatmadja ( address : Website : Office address : Jl. Angkasa No. 20 A Jakarta – 10620 Indonesia Phone : Fax : ;

33 REGULATORY FUNCTION ON PHARMACEUTICALS IN INDONESIA

34 NATIONAL AGENCY OF DRUG AND FOOD CONTROL (NADFC)
as National Regulatory Authority in Indonesia, consistent with : Good Drug Regulatory Practices (GDRP); QA ; Standardization; Self-regulatory Code; Inspection and Audit Good Management Practices (GMgP); Transparancies and fairness; SOPs; Cost- recovery; incentive/ disincentive

35 ~ REGULATORY SYSTEM for Pharmaceuticals in Indonesia
Consistency in regulation Transparency of services ~ Multi National Companies Domestic Companies No discrimination on Standard and Requirement

36 PHARMACEUTICALS (DRUGS AND BIOLOGICALS)
SISPOM (National System on D&F Control) IMPORT IMPORT QUALITY, SAFETY, and EFFICACY of PHARMACEUTICALS EXPORT EXPORT SISPOM

37 REGISTRATION DOSSIER Registration dossier for all pharmaceutical products (drug and biological products) should be submitted in ACTD (ASEAN Common Technical Dossier) format in line with ASEAN harmonization.

38 For further information, please contact : National Agency of Drug and Food Control (NADFC)
Head of National Agency of Drug and Food Control : Dra. Kustantinah, Pharmacist, MAppSc. Website : Jl. Percetakan Negara No. 23 Jakarta – Indonesia Phone : / / Fax : address :

39 GENERAL TRADING & DISTRIBUTOR
PT BINA SAN PRIMA GENERAL TRADING & DISTRIBUTOR PT Bina San Prima was established in 1994 38 branches and 17 sub distributors throughout Indonesia Total 4,035 employees including 155 sales supervisor, 755 salesmen Vehicle : 355 canvassing cars, 142 motor boxes COMPETITIVE ADVANTAGES Strong financial back up Same day delivery service Strong field forces Excellent coverage Computer integrated information system Nationwide distribution network Professionally managed

40 PRODUCT CATEGORY PRINCIPAL Pharmaceutical products
(human & veterinary) PT Sanbe Farma, PT Caprifarmindo Herbals PT Air Mancur, PT Mulya Putra Mandiri Food & Beverages (cheese, biscuit, dairy product, cooking oil) PT Mead Johnson Indonesia PT Ultra Jaya, PT Kraft Food Indonesia PT Indofood, PT Siantar Top, etc. Confectionaries PT Perfetti van Melle, PT Tora Nusantara Personal Care PT Beiersdorf, PT Dua Berlian Other consumer products (lighting, lubricant oil) PT Shell Indonesia, PT Philips Indonesia

41 ACHIEVEMENT AWARDS AWARDS PRINCIPAL
The Best Achievement of Business Plan 2009 Shell Companies in Indonesia Best Revenue Growth Semester I 2009 PT Kraft Food Indonesia Best Growth Distribution 2009 category A,B,C PT Nutrifood Indonesia Top 5 Best Volume Achievement 2008 HSSE Award 2008 Top 5 Best Regional Distributor 2008 PT Beiersdorf Indonesia 5 Years Distribution Service

42 ACHIEVEMENT AWARDS AWARDS PRINCIPAL The Best Target Achievement 2007
PT Reckitt Benckiser Indonesia The Runner Up Volume Growth 2007 Shell Companies in Indonesia The Best Volume Achievement West Java 2007 The Best Volume Achievement Palembang 2007 The Best in Operation Excellence 2006 The Best Growth 2006 The Best Target Achievement 2005 The Best Performance 2005 PT Nutrifood Indonesia The Best Business Growth 2004 PT Procter & Gamble Indonesia

43 Operation & Brand Director : Andi MS
Contact Us : PT BINA SAN PRIMA Operation & Brand Director : Andi MS address : Phone : ext. 502 – 503 Fax : Jl. Purnawarman 47 Bandung 40116 West Java - Indonesia

44 CONCLUSION The Indonesian Pharmaceutical market is still potential enough considering the population number, GDP and drug consumption per capita NADFC as the regulatory authority in Indonesia commits to treat the foreign and domestic pharmaceutical companies with same standard and requirement.

45 FOOD & BEVERAGES, WOOD, PULP & PAPER BUSINESS OPPORTUNITY IN INDONESIA
Presented by : Drs. Jahja Santoso, Pharmacist Honorary Consul of The Republic of Latvia For West Java & Bali June 07, 2011

46 Indonesia Consumers’ Characteristics
30 millions live in big city with sufficient buying power 100 millions low buying power, 38 millions poor 60% live in Java island, 21% in Sumatera 58% live in rural area, 42% in city 87% Moslems (200 millions) : need Halal Foods 55% < 25 years old 480 ethnics in Indonesia Rice is a main staple food

47 Characteristics of Food & Beverages Business in Indonesia
Total consumption of Food & Beverages & tobacco in 2009 : +/- Rp 1,700 trillion Fresh & unprocessed foods : +/- Rp 1,000 trillion Consumption of processed foods : +/- Rp 505 trillion Consumption of cigarettes & processed tobacco: +/- Rp 120 trillion Many malls & modern retails are built (Mini / Super / Hypermarket) Note : USD 1 = Rp 9,000

48 Characteristics of Food & Beverages Business in Indonesia
Competitive Environment 1,159,983 food & beverages industries consist of : - 6,316 big / medium industries - 66,178 small industries - 1,087,489 home industries 10,226,595 units of wholesaler/retailer Multinational companies have entered food & beverages industry, modern retail, fast food, hotel, restaurant and plantation. Imported raw material is still relatively high (e.g. flour, milk, soybean, meat)

49 Output of Food Industries in Indonesia 2003 - 2008 ( in million US$)
Scale of Industry Year 2003 2004 2005 2006 2007 2008* Big & Medium 18,043 19,035 22,673 29,396 37,283 48,443 Small 1,261 1,509 2,412 4,107 3,035 3,330 Home industry 2,165 2,243 2,367 4,575 4,404 4,400 Total **) 21,469 22,787 27,452 38,078 44,722 56,173 Source : Statistic of Indonesia 2009, Central Bureau of Statistics ( *) temporary data

50 EXPORT & IMPORT OF PROCESSED FOODS (2003 – 2009*) (in million US$)
2004 2005 2006 2007 2008 2009* Export 1,242 1,519 1,806 1,966 2,264 2,997 2,060* Import 798 827 1,086 1,216 1,950 1,903 1,224** Sumber : Central Bureau of Statistics 2009 (*) Jan – Sept’ 2009 (**) Jan - Nov’ 2009

51 Stakeholder Support BSN* Customers Employees Regulators
INDUSTRY/ ASSOCIATION Society / MASTAN Government / Institutions * BSN = National Standardization Agency of Indonesia

52 For further information, please contact :
INDONESIAN FOOD & BEVERAGES ASSOCIATION CHAIRMAN : Adhi Lukman SECRETARY GENERAL : Franky Sibarani ( address : Head of Secretariat: Virocano Hengki Data Center & Information: Tri Cahyanto (Nanang) IT & Back Office: Bobby Kusumo

53 INDONESIAN FOOD & BEVERAGES ASSOCIATION
Office Address : Head Office of Ministry of Agriculture Building F 2nd Floor, Room No. 224-A Jl. Harsono RM No. 3 Ragunan - Pasar Minggu Jakarta Phone : Fax. : website:

54 Pulp & Paper Industry FOREIGN INVESTMENT REALIZATION IN PULP & PAPER INDUSTRY (January 1, 2005 to December 31, 2009) Year Country Investment value (in thousand USD) 2005 Singapore 5,336 2006 Mauritius Seychel USA South Korea 377,124 270,668 21,100 3,620 50 2007 Taiwan Netherland 417,866 235,218 196 2008 Mixed countries 123,762 2009 UK 39,815 9,995 6,578 3,300

55 Wood Industry FOREIGN INVESTMENT REALIZATION IN WOOD INDUSTRY
(January 1, 2005 to December 31, 2009) Year Country Investment value (in thousand USD) 2005 Japan Hongkong South Korea Taiwan China Malaysia USA Germany Mixed countries 1,610 62,659 505 1,100 177 8,281 412 240 512 2006 Singapore Pakistan Australia 7,364 1,871 1,025 23,162 250 650 24,574

56 Wood Industry FOREIGN INVESTMENT REALIZATION IN WOOD INDUSTRY
(January 1, 2005 to December 31, 2009) Year Country Investment value (in thousand USD) 2007 Mauritius Singapore Japan Mixed countries South Korea 55,025 48,183 14,450 7,030 3,165 2008 Malaysia China Taiwan Australia Denmark 38,644 32,388 25,000 13,845 3,625 2,570 1,595 1,350 450

57 Wood Industry FOREIGN INVESTMENT REALIZATION IN WOOD INDUSTRY
(January 1, 2005 to December 31, 2009) Year Country Investment value (in thousand USD) 2009 Singapore Mixed countries Japan Taiwan Hongkong South Korea UK Pakistan 32,332 21,534 5,025 879 878 800 350 300

58 For further information, please contact :
* ASSOCIATION OF INDONESIA PULP & PAPER Chairman : M. Mansur Secretary General : Kahar Haryoppuspito Office Address : Jl. Cimandiri 6 Flat 1 No. 2 Jakarta 10330 Phone : Fax :

59 For further information, please contact :
* INDONESIAN WOOD PANEL PRODUCERS ASSOCIATION Chairman : Martias Secretary General : AA Malik Office Address : Manggala Wanabakti Building Block IV Wing A 9th Floor Jl. Jend. Gatot Subroto Jakarta 10270 Phone : Fax : /

60 For further information, please contact :
* INDONESIAN SAWMIL & WOOD WORKING MANUFACTURERS ASSOCIATION Chairman : Dra. Hj. Soewarni. MM Secretary General : Drs. Sri Oetom Office Address : Manggala Wanabakti Building Block IV Wing C 8th Floor Jl. Jend. Gatot Subroto Jakarta 10270 Phone : Fax : /

61 Thank You For Your Kind Attention
Drs. Jahja Santoso, Pharmacist Honorary Consul of The Republic of Latvia For West Java & Bali June 07, 2011


Download ppt "SPEAKER’S PROFILE Drs. Jahja Santoso, Pharmacist"

Similar presentations


Ads by Google